Prominent glabella-microcephaly-hypogenitalism syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2083OMIM:247990Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Prominent glabella-microcephaly-hypogenitalism syndrome (also known as Juberg-Hayward syndrome or orocraniodigital syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial, genital, and digital anomalies. The condition was first described by Juberg and Hayward in 1969. Key clinical features include microcephaly (abnormally small head), a prominent glabella (the area between the eyebrows), cleft lip and/or cleft palate, hypogenitalism (underdevelopment of the genitalia), and hand anomalies including hypoplastic or absent thumbs and short fingers. Additional features may include growth retardation, intellectual disability of variable severity, and renal anomalies. The craniofacial features are typically apparent at birth and include a flat nasal bridge with the characteristically prominent glabella giving a distinctive facial appearance. The digital anomalies primarily affect the thumbs, which may be small, abnormally placed, or absent. Males may present with micropenis, cryptorchidism, or hypospadias, while females may show hypoplastic labia. There is no specific curative treatment for this syndrome. Management is supportive and symptomatic, involving surgical correction of cleft lip/palate, reconstructive hand surgery when indicated, hormonal evaluation and management for hypogonadism, and developmental support services for children with intellectual disability. A multidisciplinary approach involving geneticists, plastic surgeons, orthopedic specialists, endocrinologists, and developmental pediatricians is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Prominent glabella-microcephaly-hypogenitalism syndrome.

View clinical trials →

No actively recruiting trials found for Prominent glabella-microcephaly-hypogenitalism syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Prominent glabella-microcephaly-hypogenitalism syndrome community →

No specialists are currently listed for Prominent glabella-microcephaly-hypogenitalism syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Prominent glabella-microcephaly-hypogenitalism syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Prominent glabella-microcephaly-hypogenitalism syndromeForum →

No community posts yet. Be the first to share your experience with Prominent glabella-microcephaly-hypogenitalism syndrome.

Start the conversation →

Latest news about Prominent glabella-microcephaly-hypogenitalism syndrome

No recent news articles for Prominent glabella-microcephaly-hypogenitalism syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Prominent glabella-microcephaly-hypogenitalism syndrome

What is Prominent glabella-microcephaly-hypogenitalism syndrome?

Prominent glabella-microcephaly-hypogenitalism syndrome (also known as Juberg-Hayward syndrome or orocraniodigital syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial, genital, and digital anomalies. The condition was first described by Juberg and Hayward in 1969. Key clinical features include microcephaly (abnormally small head), a prominent glabella (the area between the eyebrows), cleft lip and/or cleft palate, hypogenitalism (underdevelopment of the genitalia), and hand anomalies including hypoplastic or absent thumbs a

How is Prominent glabella-microcephaly-hypogenitalism syndrome inherited?

Prominent glabella-microcephaly-hypogenitalism syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Prominent glabella-microcephaly-hypogenitalism syndrome typically begin?

Typical onset of Prominent glabella-microcephaly-hypogenitalism syndrome is neonatal. Age of onset can vary across affected individuals.